ScholarIQanswers from OpenAlex

A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder

PaperCitations, authors & open-access status

A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder have?

ScholarIQcitation count

A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder has 171 citations in the OpenAlex counts ScholarIQ stores.

When was A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder published?

ScholarIQyear

A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder has 1993 year in the ScholarIQ index.

What is the open-access status of A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder?

ScholarIQoa status

A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder has closed oa status in the ScholarIQ index.

What is the DOI of A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder?

ScholarIQdoi

The DOI for A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder is on the source record.

What is the PMID of A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder?

ScholarIQpmid

The PMID for A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder is on the source record.

What is the OpenAlex record for A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder?

ScholarIQopenalex

The OpenAlex for A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial